Advanced search
Publication Cover
Nordic Journal of Psychiatry Volume 56, 2002 - Issue 1
Submit an article Journal homepage
96
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?

Anne Mari Sund Department of Psychiatry and Behavioural Medicine, Norwegian University of Science and Technology, Trondheim, Norway
&
Pål Zeiner Centre for Child and Adolescence Psychiatry, University of Oslo, Oslo, Norway
Pages 53-57 | Published online: 12 Jul 2009

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Stephen V Faraone. (2007) Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release). Expert Opinion on Pharmacotherapy 8:13, pages 2127-2134.
Read now
Alison Poulton. (2006) Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder. Expert Review of Neurotherapeutics 6:4, pages 551-561.
Read now

Articles from other publishers (30)

Sara Carucci, Carla Balia, Antonella Gagliano, Angelico Lampis, Jan K. Buitelaar, Marina Danckaerts, Ralf W. Dittmann, Peter Garas, Chris Hollis, Sarah Inglis, Kerstin Konrad, Hanna Kovshoff, Elizabeth B. Liddle, Suzanne McCarthy, Peter Nagy, Pietro Panei, Roberta Romaniello, Tatiana Usala, Ian C.K. Wong, Tobias Banaschewski, Edmund Sonuga-Barke, David Coghill & Alessandro Zuddas. (2021) Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 120, pages 509-525.
Crossref
Kanchana KoonrungsesomboonNut Koonrungsesomboon. (2020) The Effects of Methylphenidate Treatment on Child Growth in Thai Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 30:3, pages 189-197.
Crossref
Susanne Walitza, Manfred Gerlach, Marcel Romanos & Tobias Renner. 2016. Neuro-/Psychopharmaka im Kindes- und Jugendalter. Neuro-/Psychopharmaka im Kindes- und Jugendalter 289 331 .
Elizabeth B. HarstadAmy L. WeaverSlavica K. KatusicRobert C. Colligan, Seema Kumar, Eugenia ChanRobert G. Voigt & William J. Barbaresi. (2014) ADHD, Stimulant Treatment, and Growth: A Longitudinal Study. Pediatrics 134:4, pages e935-e944.
Crossref
Susanne Walitza, Marcel Romanos, Andreas Warnke, Laurence Greenhill & Manfred Gerlach. 2014. Psychiatric Drugs in Children and Adolescents. Psychiatric Drugs in Children and Adolescents 293 333 .
Judith S. Renes, Maria A. J. de Ridder, Petra E. Breukhoven, Annemieke J. Lem & Anita C. S. Hokken-Koelega. (2012) Methylphenidate and the Response to Growth Hormone Treatment in Short Children Born Small for Gestational Age. PLoS ONE 7:12, pages e53164.
Crossref
Alfred Tenore & Andrew Tenore. (2012) A Pathophysiologic Approach to Growth Problems in Children with Attention-Deficit/Hyperactivity Disorder. Endocrinology and Metabolism Clinics of North America 41:4, pages 761-784.
Crossref
Bianca Lee Negrao & Margaretha Viljoen. (2011) Stimulants and growth in children with attention-deficit/hyperactivity disorder. Medical Hypotheses 77:1, pages 21-28.
Crossref
Stephen V. Faraone, Thomas J. Spencer, Scott H. Kollins & Stephen J. Glatt. (2010) Effects of Lisdexamfetamine Dimesylate Treatment for ADHD on Growth. Journal of the American Academy of Child & Adolescent Psychiatry 49:1, pages 24-32.
Crossref
Radek Ptacek, Hana Kuzelova & Ivo Paclt. (2017) Effect of Stimulants on Growth of ADHD Children: A Critical Review. Activitas Nervosa Superior 51:4, pages 140-146.
Crossref
Lina Felípez & Timothy A. Sentongo. (2009) Drug-Induced Nutrient Deficiencies. Pediatric Clinics of North America 56:5, pages 1211-1224.
Crossref
Laurie Kelly McCorryPamela C. Heaton & Kelly Swensgard. 2009. Community Pharmacy Practice Case Studies. Community Pharmacy Practice Case Studies.
Stephen V. Faraone, Joseph Biederman, Christopher P. Morley & Thomas J. Spencer. (2008) Effect of Stimulants on Height and Weight: A Review of the Literature. Journal of the American Academy of Child & Adolescent Psychiatry 47:9, pages 994-1009.
Crossref
STEPHEN V. FARAONE, JOSEPH BIEDERMAN, CHRISTOPHER P. MORLEY & THOMAS J. SPENCER. (2008) Effect of Stimulants on Height and Weight. Journal of the American Academy of Child & Adolescent Psychiatry 47:9, pages 994-1009.
Crossref
Benedetto Vitiello. (2008) Understanding the Risk of Using Medications for Attention Deficit Hyperactivity Disorder with Respect to Physical Growth and Cardiovascular Function. Child and Adolescent Psychiatric Clinics of North America 17:2, pages 459-474.
Crossref
Thomas J. SpencerChristopher J. KratochvilR. Bart SangalKeith E. SaylorCharles E. BaileyDavid W. DunnDaniel A. GellerCharles D. CasatRobert S. LipetzRakesh JainJeffrey H. NewcornDustin D. RuffPeter D. FeldmanAmanda J. FurrAlbert J. Allen. (2007) Effects of Atomoxetine on Growth in Children with Attention-Deficit/Hyperactivity Disorder Following up to Five Years of Treatment. Journal of Child and Adolescent Psychopharmacology 17:5, pages 689-699.
Crossref
Alison Poulton. (2006) Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder. Current Opinion in Pediatrics 18:4, pages 427-434.
Crossref
CHRISTOPHER J. KRATOCHVIL, TIMOTHY E. WILENS, LAURENCE L. GREENHILL, HAITAO GAO, KURT D. BAKER, PETER D. FELDMAN & DOUGLAS L. GELOWITZ. (2006) Effects of Long-Term Atomoxetine Treatment for Young Children With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry 45:8, pages 919-927.
Crossref
ALICE CHARACH, MAX FIGUEROA, SHIRLEY CHEN, ABEL ICKOWICZ & RUSSELL SCHACHAR. (2006) Stimulant Treatment Over 5 Years: Effects on Growth. Journal of the American Academy of Child & Adolescent Psychiatry 45:4, pages 415-421.
Crossref
Wendell W. NeeleyIIII, G. Thomas Kluemper & Lon R. Hays. (2006) Psychiatry in orthodontics. Part 1: Typical adolescent psychiatric disorders and their relevance to orthodontic practice. American Journal of Orthodontics and Dentofacial Orthopedics 129:2, pages 176-184.
Crossref
Mari Golub, Lucio Costa, Kevin Crofton, Deborah Frank, Peter Fried, Beth Gladen, Rogene Henderson, Erica Liebelt, Shari Lusskin, Sue Marty, Andrew Rowland, John Scialli & Mary Vore. (2005) NTP‐CERHR Expert Panel Report on the reproductive and developmental toxicity of amphetamine and methamphetamine. Birth Defects Research Part B: Developmental and Reproductive Toxicology 74:6, pages 471-584.
Crossref
Mari Golub, Lucio Costa, Kevin Crofton, Deborah Frank, Peter Fried, Beth Gladen, Rogene Henderson, Erica Liebelt, Shari Lusskin, Sue Marty, Andrew Rowland, John Scialli & Mary Vore. (2005) NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methylphenidate. Birth Defects Research Part B: Developmental and Reproductive Toxicology 74:4, pages 300-381.
Crossref
Thomas J. Spencer, Jeffrey H. Newcorn, Christopher J. Kratochvil, Dustin Ruff, David Michelson & Joseph Biederman. (2005) Effects of Atomoxetine on Growth After 2-Year Treatment Among Pediatric Patients With Attention-Deficit/Hyperactivity Disorder. Pediatrics 116:1, pages e74-e80.
Crossref
Abdullah Bereket, Serap Turan, M. Goksin Karaman, Goncagul Haklar, Fatih Ozbay & M. Yanki Yazgan. (2005) Height, Weight, IGF-I, IGFBP-3 and Thyroid Functions in Prepubertal Children with Attention Deficit Hyperactivity Disorder: Effect of Methylphenidate Treatment. Hormone Research in Paediatrics 63:4, pages 159-164.
Crossref
Stephen V. FaraoneJoseph BiedermanMichael MonuteauxThomas Spencer. (2005) Long-Term Effects of Extended-Release Mixed Amphetamine Salts Treatment of Attention- Deficit/Hyperactivity Disorder on Growth. Journal of Child and Adolescent Psychopharmacology 15:2, pages 191-202.
Crossref
Daniel J. Safer. (2004) A Comparison of Risperidone-Induced Weight Gain Across the Age Span. Journal of Clinical Psychopharmacology 24:4, pages 429-436.
Crossref
Mark L Wolraich & Melissa A Doffing. (2004) Pharmacokinetic Considerations in the Treatment of Attention-Deficit Hyperactivity Disorder with Methylphenidate. CNS Drugs 18:4, pages 243-250.
Crossref
S. Walitza, J. Seifert, A. Warnke & M. Gerlach. 2004. Neuro-Psychopharmaka im Kindes- und Jugendalter. Neuro-Psychopharmaka im Kindes- und Jugendalter 177 190 .
. (2002) Current Awareness: Pharmacoepidemiology and Drug Safety. Pharmacoepidemiology and Drug Safety 11:7, pages 621-636.
Crossref
. (2002) Current Awareness. Human Psychopharmacology: Clinical and Experimental 17:5, pages 257-266.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.